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Enteroaggregative Escherichia coli (EAEC) is a newly
diarrheagenic agent wherein several predominant
serotypes are reported. We studied the association
between those serotypes, as clonal indicators, and the trait
of enteroaggregative adherence to host cells, tested by
polymerase chain reaction. We also evaluated the clinical
manifestations of infection in 17 hospitalized children by
our most common EAEC serotype, O126:H27. 
E
nteroaggregative  Escherichia coli (EAEC) is an
emerging pathogen that causes diarrhea in many parts
of the world, including children from Israel (1) and Jordan
(2). This group of E. coli was preliminarily defined by its
aggregative pattern of adherence (AA) to HEp-2 cells (3).
Their identification was facilitated by a DNAprobe devel-
oped from a plasmid (pCVC432 syn. pAA) necessary for
expressing the aggregative phenotype (4). Based on that
probe, a polymerase chain reaction (PCR) test was devel-
oped for screening EAEC strains (5). This test, which we
used in this research, and another test using the same DNA
probe (6), have been better indicators of diarrheagenic
strains than the phenotypic Hep-2 cells test.
EAEC is a divergent group in terms of the organ-
isms’ability to induce diarrhea (7), the factors involved in
attachment to host cells (8), and kinds of serotypes (8,9).
Since certain EAEC serotypes were already prevalent
throughout the world, we studied whether those strains
could be found in our isolates of diarrheagenic EAEC. To
simplify the detection of EAEC, we selected a bacterio-
phage active specifically on our clinically evaluated EAEC
strains of E. coli O126:H27. EAEC have been rarely eval-
uated clinically in Israel. Here we address that problem by
reporting clinical and microbiologic findings of children
hospitalized with gastroenteritis in which our most com-
mon EAEC serotype, O126:H27, was found.
The Study 
Clinical signs and the laboratory findings were evaluat-
ed for 17 children <2 years of age, hospitalized in four
pediatric wards in different areas of Israel. All these chil-
dren had gastroenteritis attributable to EAEC or enterotox-
igenic E. coli (ETEC) of serotype O126:H27 (Table 1). 
Serotyping was performed (10). To determine O-anti-
gen, cultures were heated to 120°C for 1 h, then checked
for agglutination with specific O-antisera at 50°C
overnight. For determination of H-antigen, motile cultures
were grown overnight in nutrient broth, treated with 0.5%
formaldehyde, and investigated for agglutination with spe-
cific H-sera at 50°C for 2 h.
To detect EAEC, we used PCR primers specific for a
short sequence of the plasmid pAA of EAEC, which is
necessary for adherence. Analysis for the presence of
pCVD432 sequences was performed at the Institute of
Hygiene and Microbiology, the University of Wuerzburg,
and the Institute of Medical Microbiology and Hygiene,
Technical University of Dresden, Germany. Briefly, E. coli
were isolates grown overnight on L-agar, and a single
colony was suspended in 50 µL of phosphate-buffered
saline (PBS). Amplification was carried out in a total vol-
ume of 50 µL containing each nucleotide triphosphate at
200 µm, 30 pmol of each primer, 5 µL of 10-fold concen-
trated AmpliTaq DNA polymerase synthesis buffer, 1.5
mM MgCL2, 2.5 U AmpliTaq DNA polymerase (Applied
Biosystems Applera, Weiterstadt, Germany), and 5 µLo f
template Oligonucleotides pCVD432/start (5′-CTG GCG
AAA GAC TGT ATC AT-3′) and pCVD432/stop (5′-AAT
GTA TAG AAA TCC GCT GT-3′) were purchased from
Sigma-ARK GmbH (Darmstadt, Germany) (5). The PCR
protocol comprises 30 rounds of amplification, each con-
sisting of 30 s at 94°C, 60 s at 52°C, and 60 s at 72°C. The
first cycle was preceded by a denaturation step of 10 min
at 94°C, and the last extension cycle was followed by a
final extension step of 10 min at 72°C. 
Enterotoxins were determined by the Asialogang-
lioside-GM1 enzyme-linked immunosorbent assay (GM1-
ELISA) method using the direct plate cultures technique.
Heat-labile toxin (LT) was determined by GM1-ELISA
using monoclonal antibodies against LT (11). Heat-stable
toxin (ST) was determined in parallel in the same cultures
by an inhibition-GM1-ELISA that used monoclonal anti-
ST (12). The test was performed in two 96-well poly-
styrene microplates A&B (Nunc A/S Roskilde, Denmark)
and comprises several steps. The plates were coated with
GM1 by adding 0.1 mL of 0.3 nmol GM1 (Sigma, Rehovot,
Israel) in 0.1 M PBS, pH=7.2, to each well. After the plates
incubated overnight at room temperature, they were
washed three times with PBS, blocked with 0.1% bovine
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Israelserum albumin (BSA) in PBS for 30 min at 37°C, and
finally washed once with PBS. To each of the GM1-coated
wells in plate Awas added 0.2 mLLB broth, Lennox medi-
um, adjusted to 45 µg lincomycin/mL and 2.5 mg glu-
cose/mL. From each bacterial isolate, five colonies grown
on McConkey agar were transferred directly into five sep-
arate wells. The cultures were grown for 24 h at 37°C with
moderate shaking. Plate B (without the bacterial cultures)
was processed after step 1 in a different way to determine
ST. Briefly, plate B was coated with ST-CTB (consisting of
the B-subunit of cholera toxin conjugated to ST) by adding
0.1 mL of ST-CTB in 0.1% BSA–PBS to each well and
incubation of the plate at room temperature for 60 min.
Then the plate was washed three times with PBS. To each
well in plate B, 0.05 mL of culture medium from plate A
was added (presumed to contain ST); immediately there-
after, 0.05 mL of the monoclonal antibody against ST
(anti-ST) was added, and the plate was gently shaken. The
plate was incubated for 90 min at room temperature and
then washed three times with 0.05% PBS-Tween. After the
culture medium was disposed of, plate Awas washed three
times with PBS-Tween. To each well, 0.1 mL of mono-
clonal antibody against LT (anti-LT) in PBS-BSA-Tween
was then added. The plate was incubated for 90 min at
room temperature and then washed three times with PBS-
Tween. To each well of plates Aand B we added 0.1 mLof
goat anti-mouse immunoglobulin G–horseradish perioxi-
dase (Jackson Immuno-Research Laboratories, West
Grove, Pennsylvania) in PBS-BSA-Tween. The plates
were incubated for 90 min at room temperature and then
washed three times with PBS-Tween. Substrate was pre-
pared by dissolving 10 mg of ortophenylene diamine
(Sigma) in 10 mL of 0.1 M sodium citrate buffer (pH=4.5)
to which 4 µL of 30% H2O2was added. To each well in
plates A and B, 0.1 mL of this substrate solution was
added. After 20 min, the plates were read at 450 nm in a
Micro ELISA Auto Reader spectrophotometer (Dynatech
Inc., Alexandria, VA).
When the optical density (OD) decreased >50% as
compared with the OD of anti-ST mixed with ST negative
control culture, which run in parallel to the experimental
wells, the result was considered ST positive. When the OD
value at 450 was >0.100 above the background, the result
was considered LT positive. Since serotype O126:H27 was
prevalent in our EAEC cultures, we tried to isolate bacte-
riophages specific to the EAEC of this serotype from
sewage water. Five unrelated strains of EAEC serotype
O126:H27 were used. One milliliter of an early logarith-
mic broth culture of each strain was seeded in a bottle of
50-mL nutrient broth. After incubation of 3 h at 37°C, 5
mL of sewage water was added to each bottle. After a new
incubation of 6 h, cultures were killed by adding 1 mL of
chloroform, followed by intensive shaking. The next day
the supernatant of each bottle was tested for activity on the
respective strain. The isolated phages were then diluted
and purified twice by single plaque isolation (13). The five
phages were active on EAEC strains of serotype
O126:H27. 
From July 1999 to December 2001, we collected and
characterized 1,368 isolates of diarrheagenic E. coli. Of
these isolates, 88 (6.4%) belonged to one of the five most
common EAEC serotypes, i.e., serotype O126:H27
(n=48), O111:H21 (n=16), O125 (n=11), O44:H18 (n=11),
O?:H10 (n=2) (Table 2). The percentages of EAEC
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Table 1. Bacteriologic parameters and clinical signs of children with Escherichia coli O126:H27  
No.  Age (mo)  EAEC-PCR 
Phage 
sensitivity  ST  Diarrhea (days)  Dehydration  IV fluid  Vomit  Fever 
Concomitant 
 clinical findings 
1  6  +  +  -  + (12)  +  +  +  + 39   
2  1.5  +  +  -  + (40)  +  +  -  -  Malabsorption, prolonged 
diarrhea 
5  +  +  -  + (4)  +  +  +  + 40   
4  2  +  +  -  + (4)  +  +  +  -   
5  15  +  +  -  + (2)  +  +  +  + 40   
6  21  +  +  -  + (4)  +  +  +  + 39  Tonsillitis 
7  18  +  +  -  + (1)  -  -  -  -   
8  16  +  +  -  +(9)  +  +  -  +39  Otitis 
9  11  +  +  -  + (8)  +  +  -  +40  Tonsillitis 
10  16  +  +  -  + (9)  +  +  +  +40   
11  15  +  +  -  + (7)  -  +  -   +39  UTI 
12  1  +  +  +  +(2)  +  +  -  -   
13  15  +  +  +  +(6)  -  +  -   +40  Tonsillitis leukocytosis 
14  1.5  +  NT  +  + (5)  -  +  -  +38.7  Meningitis 
15  6  +  NT  +  +(1)  +  +  +  +40   
16  1 week  -  -  +  +(6)  +  +  -  -   
17  9  -  -  +  + (5)  +  +  +  +40   
aEAEC, enteroaggregative Escherichia coli; PCR, polymerase chain reaction; ST, heat-stable toxin; UTI, urinary tract infections; NT, not tested.  
3PCR–positive strains (Table 2) were as follows: 73% in E.
coli O126:H27 and 75% in E. coli O111:H21. In E. coli
O125, the percentage was approximately 50%, and in E.
coli O44:H18, unlike reported elsewhere (14), this per-
centage was low.
To determine if the isolated phages were specific for the
enteroaggregative strains of serotype O126:H27, the five
phages were tested by spot test at routine test dilution on
our EAEC and non–EAEC cultures of this serotype. Four
phages were active on both kinds of strains. Only phage
no. 4 was active on 33 of the 34 EAEC cultures and on 1
of 12 non-EAEC cultures (Table 3). The sensitivity of this
phage was 97%, and its specificity was 91%. This phage
could therefore be used as an indicator for AA in this E.
coli serotype. 
E. coli O126: H27 was found in stools from 17 children
in four pediatric wards in various areas in Israel (Table 1).
The stools were watery; no mucus or blood was seen. Most
of the children were dehydrated and needed IV treatment
with fluids and electrolytes. Some children vomited sever-
al times. All 17 patients had a normal leukocyte count for
age. Twelve of them had high fever (38.7°C–40°C). Three
of these 12 children had diarrhea concomitant with other
diseases (patients 11, 13, and 14). Stool cultures of these
three children were taken as part of an investigation of
febrile disease. The same three children received antibiot-
ic treatment; all others recovered without antibiotics. The
length of hospitalization was 2–8 days. The duration of
diarrhea was 1–40 days (median 5 days) starting, in some
cases, before hospitalization. ST was produced in six
patients (nos. 12–17), while LT was not produced in any.
Five patients (nos. 1, 2, 8, 9, 10) had prolonged diarrhea of
>1 week, characteristic of EAEC (15).
Conclusions 
In our patients, EAEC serotype O126:H27 appears to
be a pathogenic agent of young children who require hos-
pitalization and dehydration treatment. This same serotype
has been reported as a common cause of diarrhea in chil-
dren from England (16), Japan (17), and Bangladesh (9).
However, we were not able to associate that serotype
exclusively with the enteroaggregative pathotype, since
nonaggregative Ec O126;H27 strains from hospitalized
children (patients 16 and 17 in Table 1) produced ST and
might therefore belong to the pathotype of ETEC. 
However, ST was apparently not the main diar-
rheagenic factor, since in the five children with prolonged
diarrhea no ST was produced. Some other kind of toxin
was probably involved in these cases. In strains from some
patients (Table 1, numbers 12–15) we found both traits of
EAEC and ETEC in the same organism.  A simple test to
identify EAEC in routine laboratory work is needed. A
possible solution is to use a phage sensitivity test in addi-
tion to serotyping, such as we used here for EAEC
O126:H27. Preliminary results suggest that this test (Table
3) is a reliable indicator. If this fact is confirmed on a large
number of strains, specific phages might also be selected
for EAEC of other serotypes.
The obvious accumulation of pCVD432-positive E. coli
of serotype O126:H27 suggests that we found a clone that
spread in Israel and probably has a selective advantage. 
Acknowledgments
The monoclonal antibodies and the CTB-ST (heat-stable
toxin conjugated to cholera toxin subunit B) conjugate for these
tests were kindly supplied by Ann-Mari Svennerholm.
Dr. Shazberg is a senior physician in a pediatric department.
Her research interest is pediatric infectious diseases.
References
1. Porath N, Levy A, Fraser D, Deckelbaum RJ, Dagan R. Prevalence of
intestinal infections caused by diarrheagenic Escherichia coli in
Bedouin infants and young children in southern Israel. Pediatr Infect
Dis J 1998;17:482–8.
2. Yousef M, Shurman A, Bougnoux M-A, Bretagne S, Stockbine N.
Bacterial viral and parasitic enteric pathogens associated with acute
diarrhea in hospitalized children from northern Jordan. FEMS
Immunol Med Microbiol 2000;28:257–63
3. Nataro JP, Kaper JB, Robins BR, Pardo V, Vial P, Levine MM.
Patterns of adherence of diarrheagenic Escherichia coli in Hep2 cells.
Pediatr Infect Dis J 1987;6:829–31.
4. Baudry B, Savarino SJ, Vial P, Kaper JB, Levine MM. Asensitive and
specific DNA probe to identify enteroaggregative Escherichia coli
recently discovered diarrheal pathogen. J Infect Dis
1990;161:249–51.
5. Schmidt H, Knop C, Franke S, Alecxis S, Heeserman J, Karch H.
Development of PCR for screening of enteroaggregative Escherichia
coli. J Clin Microbiol 1995;33:701–5.
6. Knutton S, Shaw R, Phillips AD, Smith HR, Willshaw GA, Wtson P,
et al. Phenotypic and genetic snslysis of diarrhea-associated
Escherichia coli isolated from children in the United Kingdom. J
Pediatr Gastroenterol Nutr 2001;33:32–40.
1172 Emerging Infectious Diseases • Vol. 9, No. 9, September 2003
DISPATCHES
Table 2. Serotypes of enteroaggregative Escherichia coli (EAEC) evaluated by polymerase chain reaction 
E. coli serotype  O126:H27  O111:H21  O125:Hx  O44:H18  O?:H10  Totals 
No. positive  35 (73%)  12 (75%)  H9=5 H49=1 6(54.5%)  2 (18%)  1  56 
No. negative  13 (27%)  4 (25%)  H49=3 H6=2 5(45.5%)  9 (82%)  1  32 
Totals  48  16  11  11  2  88 
Table 3. Phage sensitivity of Escherichia coli O126:H27 
compared to EAEC-PCR
a 
Phage sensitivity
b  EAEC-PCR positive  EAEC-PCR negative 
 Positive  33 isolates  1 isolate 
Negative  1 isolate  11 isolates 
aEAEC PCR, enteroaggregative Escherichia coli polymerase chain reaction. 
bSensitivity = 97%; specificity = 91%. 7. Okeke IN, Lamikanara A, Czezulin J, Dobovsky F, Kaper JB, Nataro
JP. Heterogenous virulence of enteroaggregative Escherichia coli
strains isolated from children in southwest Nigeria. J Infect Dis
2000;181:252–60.
8. Spencer J, Smith HR, Chart H. Characterization of enteroaggregative
Escherichia coli isolated from outbreaks of diarrheal disease in
England. Epidemiol Infect 1999;123:413–21. 
9. Qadri F, Haque A, Farouque SM, Bettelheim KA, Robin-Browne R,
Albert MJ. Hemagglutinating properties of enteroaggregative
Escherichia coli. J Clin Microbiol 1994;32:510–4.
10. Orskov F, Orskov I. Seroyping of Escherichia coli. Methods in
Microbiology 1984;14:43–112.
11. Svennerholm A-M. Heat labile enterotoxin of Escherichia coli and
Vibrio cholerae. In: Bergemeyer H-U, Bergmeyer J, Grassel M, edi-
tors. Method in enzymatic analysis. 3rd edition. Weinhem, Germany:
VCH Verlagsgeselschaft; 1986. p. 135–51.
12. Svennerholm A-M, Wikstrom M, Lindblad M, Holmgren J.
Monoclonal antibodies against Escherichia coli heat-stable toxin
(Sta) and their use in diagnostic ST ganglioside GM1-enzyme-linked
immunosorbent assay. J Clin Microbiol 1986;24:585–90.
13. Adams MH. Bacteriophages. New York: Interscience Publishers;
1959.
14. Smith HR, Scotland SM, Wilshaw GA, Row B, Cravioto A, Eslava C.
Isolates of  Escherichia coli O44;H18 of diverse origin are enteroag-
gregative. J Infect Dis 1994;170:1610–3.
15. Fang GD, Lima AAM, Martins CV, Nataro JP, Guerrant RL. Etiology
and epidemiology of persistent diarrhea in northeast Brazil: a hospi-
tal based prospective case-control study. J Pediatr Gastroenterol Nutr
1995;21:137–44.
16. Scotland SM, Smith HR, Said B, Wishaw GA, Cheasty T, Rowe B.
Identification of enteropathogenic Escherichia coli isolated in Britain
as enteroaggregative or as member of a subclass of attaching-and-
effacing E. coli not hybridizing with the EPEC adherence-factor
probe. J Med Microbiol 1991;35:278–83.
17. Kawano K, Yamada T, Yagi T, Ito K. Detection of enteroaggregative
Escherichia coli from sporadic diarrhea patients. Kaanaasenshogaku
Zasshi (Japan) 1998;72:1275–82. 
Address for correspondence: Moshe Wolk, Central Laboratories, Israel
Ministry of Health, 9 Yaakov Eliav St., POB 34410, Jerusalem 91342,
Israel; fax: 009722651828; email: Moshe.Wolk@eliav.heal.gov.il
Emerging Infectious Diseases • Vol. 9, No. 9, September 2003 1173
DISPATCHES
S Se ea ar rc ch h   p pa as st t   i is ss su ue es s   o of f   E EI ID D   a at t   w ww ww w. .c cd dc c. .g go ov v/ /e ei id d